![](/img/cover-not-exists.png)
P-280Pembrolizumab versus physician-choice chemotherapy for previously treated patients with advanced/metastatic squamous or adenocarcinoma of the esophagus or Siewert I adenocarcinoma of the esophagogastric junction (EGJ): Randomized, phase 3 KEYNOTE-18
Toshihiko, Doi, Jaafar, Bennouna, Lin, Shen, Peter, Enzinger, Ruixue, Wang, Ildiko, Csiki, Minori, Koshiji, Manish, ShahVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.270
Date:
June, 2016
File:
PDF, 69 KB
english, 2016